WallStreetZenWallStreetZen

NASDAQ: ALKS
Alkermes PLC Stock Ownership - Who owns Alkermes?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Alkermes PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David Joseph GaffinEVP CLO Alkermes Inc.2026-07-062,034$54.03
$109.90kSell
Craig C. HopkinsonEVP RD Chief Medical Officer2026-07-018,300$51.46
$427.13kSell
Craig C. HopkinsonEVP RD Chief Medical Officer2026-07-015,000$19.34
$96.70kBuy
Craig C. HopkinsonEVP RD Chief Medical Officer2026-07-01700$52.13
$36.49kSell
Christopher I. WrightDirector2026-06-122,000$45.10
$90.20kSell
David Joseph GaffinEVP CLO Alkermes Inc.2026-06-042,034$43.05
$87.56kSell
Craig C. HopkinsonEVP RD Chief Medical Officer2026-06-015,000$19.34
$96.70kBuy
Craig C. HopkinsonEVP RD Chief Medical Officer2026-06-019,000$41.67
$375.05kSell
Samuel Joseph ParisiVP Finance Interim PAO2026-05-2916,217$42.36
$687.00kSell
Samuel Joseph ParisiVP Finance Interim PAO2026-05-2912,825$19.34
$248.04kBuy

1 of 8

ALKS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALKS insiders and whales buy or sell their stock.

ALKS Shareholders

What type of owners hold Alkermes PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc16.99%28,314,410$1.50BInstitution
Baker Bros Advisors LP6.01%10,012,267$529.55MInstitution
Vanguard Portfolio Management LLC5.71%9,511,112$503.04MInstitution
State Street Corp5.68%9,465,286$500.62MInstitution
Elan Corp PLC4.65%7,750,000$409.90MInsider
Vanguard Capital Management LLC4.46%7,427,397$392.84MInstitution
Renaissance Technologies LLC3.70%6,160,428$325.83MInstitution
American Century Companies Inc3.64%6,072,103$321.15MInstitution
Price T Rowe Associates Inc2.80%4,664,576$246.71MInstitution
Dimensional Fund Advisors LP2.71%4,522,378$239.19MInstitution

1 of 3

ALKS vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALKS93.37%6.63%Net SellingNet Selling
RDY14.43%26.65%
LNTH51.87%48.13%Net SellingNet Selling
AMRX29.90%70.10%Net SellingNet Selling
ELAN91.24%8.76%Net SellingNet Selling
View Top Pharmaceutical Stocks

Alkermes Stock Ownership FAQ

Who owns Alkermes?

Alkermes (NASDAQ: ALKS) is owned by 105.74% institutional shareholders, 7.51% Alkermes insiders, and 0.00% retail investors. Elan Corp PLC is the largest individual Alkermes shareholder, owning 7.75M shares representing 4.65% of the company. Elan Corp PLC's Alkermes shares are currently valued at $408.66M.

If you're new to stock investing, here's how to buy Alkermes stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.